Results 341 to 350 of about 950,400 (402)

A review of common immunotherapy and nano immunotherapy for acute myeloid leukemia. [PDF]

Front Immunol
Wang Y, Yang X, Liu Y, Li Y.
europepmc   +1 more source

Interventional oncology in children: Where are we now?

Journal of Medical Imaging and Radiation Oncology, EarlyView.
Abstract Paediatric Interventional Oncology (IO) lags behind adult IO due to a scarcity of specific outcome data. The suboptimal way to evolve this field is relying heavily on adult experiences. The distinct tumour types prevalent in children, such as extracranial germ cell tumours, sarcomas, and neuroblastoma, differ strongly from those found in ...
Premal Amrishkumar Patel, Fernando Gómez Muñoz   +1 more
wiley   +1 more source

Unlocking the Potential of Perillaldehyde: A Novel Mechanism for Chronic Myeloid Leukemia by Targeting HSP70. [PDF]

Molecules
Zhang M, Wang J, Jiang R, Liu M, Zhang W.   +4 more
europepmc   +1 more source

Dual Inhibition of Mast Cells and Thymic Stromal Lymphopoietin Using a Novel Bispecific Antibody, CDX‐622

Allergy, EarlyView.
SCF and TSLP expression are known to drive unique immune responses leading to the onset of allergic and inflammatory diseases. Here, we describe the characterization of a novel bsAb, CDX‐622, that targets SCF and TSLP. CDX‐622 inhibits MC functions through SCF starvation and Type 2 inflammatory responses via TSLP inhibition.
Michael B. Murphy, Laura Vitale, Thomas O'Neill, Deena M. Maurer, Linda Malenchek, Andrea Crocker, Colleen Patterson, Laura Mills‐Chen, Virginia Saley, Nicole M. Antczak, James M. Boyer, Kelly M. McManus, Noe Rico Montanari, Russell A. Hammond, Joel Goldstein, Lawrence J. Thomas, Tibor Keler, Diego Alvarado   +17 more
wiley   +1 more source

α-Ketoglutarate dehydrogenase is a therapeutic vulnerability in acute myeloid leukemia.

Blood
Millman SE, Chaves-Perez A, Janaki-Raman S, Ho YJ, Morris JP, Narendra V, Chen CC, Jackson BT, Yashinskie JJ, Mezzadra R, Devine TI, Barthet VJA, Saoi M, Baslan T, Tian S, Sachs Z, Finley LWS, Cross JR, Lowe SW.   +18 more
europepmc   +1 more source

Immune checkpoints regulate acute myeloid leukemia stem cells. [PDF]

Leukemia
Reinhardt C, Ochsenbein AF.
europepmc   +1 more source

Cytarabine Pharmacogenomics and Outcomes Among Children and Young Adults With Acute Myeloid Leukemia.

JAMA Netw Open
Marrero RJ, Shastri VM, Nicolet D, Mrózek K, Walker CJ, Blum WG, Powell BL, Kolitz JE, Moore JO, Uy GL, Stock W, Carroll AJ, Byrd JC, Aplenc R, Cooper TM, Gamis AS, Wu H, Pounds S, Wang YC, Alonzo TA, Meshinchi S, Eisfeld AK, Kolb EA, Lamba JK.   +23 more
europepmc   +1 more source

Dysregulation of sphingolipid metabolism contributes to the pathogenesis of chronic myeloid leukemia. [PDF]

Cell Death Dis
Xie Y, Zeng Q, Chen Z, Song J, Wang F, Liu D, Sun X, Zhang Y, Huang Q.   +8 more
europepmc   +1 more source

Work Ability in Patients with Chronic Myeloid Leukemia: A Danish Nationwide Cohort Study. [PDF]

Cancers (Basel)
Maksten EF, Jensen JF, Thomsen G, Zenas DR, Jørgensen MP, Udby L, Fonager K, Severinsen MT.   +7 more
europepmc   +1 more source

Neutrophilic eccrine hidradenitis following dasatinib initiation in a patient with chronic myeloid leukemia. [PDF]

JAAD Case Rep
Watson A, Roberts N, Noble C, Badon H, Cruse A.   +4 more
europepmc   +1 more source